Sanai, N. (2018). Phase 0 Trial of AZD1775 in First-Recurrence Glioblastoma Patients. The American Association for Cancer Research (AACR).
Chicago Style (17th ed.) CitationSanai, N. Phase 0 Trial of AZD1775 in First-Recurrence Glioblastoma Patients. The American Association for Cancer Research (AACR), 2018.
MLA (9th ed.) CitationSanai, N. Phase 0 Trial of AZD1775 in First-Recurrence Glioblastoma Patients. The American Association for Cancer Research (AACR), 2018.
Warning: These citations may not always be 100% accurate.